Mark Douglas Smith
Independent DirectorDr. Mark Douglas Smith, M.D., M.B.A., has been an Independent Director of Teladoc Health, Inc. since October 15, 2018. He is a nationally recognized physician, healthcare policy expert and leader in care delivery innovation. He has decades of experience helping healthcare organizations scale and improve access to care, quality and value. His expertise spans healthcare policy, regulatory strategy, payment reform and scaling innovative healthcare organizations. Dr. Smith is a Member of the clinical faculty and Clinical Professor of Medicine at the University of California, San Francisco, where he also maintains a clinical practice. He serves as Director at Alchera Incorporated since August 2026. He has been an Independent Director of Phreesia, Inc. since October 26, 2018. He is an Independent Non-Executive Director of Jazz Pharmaceuticals plc since December 1, 2020. He serves as the Member of Advisory Board & Director of Concerto Healthcare, Inc. since September 2015. He serves as Director at Institute for Healthcare Improvement, Inc. and the Commonwealth Fund and is on the editorial Board of Health Affairs. He serves as a Member of Advisory Council at Capsule Technologies, Inc. (formerly known as Qualcomm Life, Inc.). He is a Founding Advisory Board Member of Health Velocity Capital and chairs the Advisory Board of the RWJF Health Policy Fellows program. He is a visiting professor at the School of Public Health at UC Berkeley and co-Chair of the Guiding of the Health Care Payment Learning and Action Network, a public-private partnership launched by the U.S. Department of Health and Human Services to accelerate the healthcare system's transition from fee-for-service care to alternative payment models (APMs), where his role includes the dissemination of innovative strategies to improve the health system and lower the costs of care. Dr. Smith previously served as the founding President and Chief Executive Officer of the California Health Care Foundation from 1996 to December 31, 2013. Prior to that, Dr. Smith served as an Executive Vice President at the Henry J. Kaiser Family Foundation from 1991 to 1996. He served as Associate Director of the AIDS Services and Assistant Professor of medicine and of health policy and management at Johns Hopkins University. He is a board-certified internist and an attending physician at the Positive Health Program for AIDS care at San Francisco General Hospital. He served as Member of Clinical Advisory Council at MedZed, LLC until September 2021. Dr. Smith served as a Director of California HealthCare Foundation until December 31, 2013. He served as a Director of Tibion Corporation. He has served on the Board of the National Business Group on Health and the editorial Board of the Annals of Internal Medicine. Dr. Smith was elected to the National Academy of Medicine in 2001. He has devoted his career to advancing healthcare policy, improving care delivery and expanding access to high-quality healthcare. Dr. Smith received a B.A. in Afro-American studies from Harvard College, an M.D. from the University of North Carolina at Chapel Hill and an M.B.A. with a concentration in health care administration from The Wharton School at the University of Pennsylvania.
Positions
- Company NamePhreesia, Inc.Stock CodePHRPositionIndependent DirectorColleagues
- CIChaim IndigCo-Founder, CEO & Director
- RSRamin SayarIndependent Chairman
- EREvan RobertsCo-Founder & President of Provider Solutions
- BGBalaji GandhiChief Financial Officer
- ACAllison C. HoffmanGeneral Counsel & Secretary
- DLDavid LinetskyPresident of Network Solutions
- GMGillian MunsonIndependent Director
- EVElsa-Grace V. GiardinaMember of Medical Advisory Board
